- Home
- PHVS vs DNN Comparison
PHVS vs DNN Comparison
Compare PHVS & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- DNN
- Stock Information
- Founded
- PHVS 2015
- DNN 1954
- Country
- PHVS Switzerland
- DNN Canada
- Employees
- PHVS N/A
- DNN N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- DNN Other Metals and Minerals
- Sector
- PHVS Health Care
- DNN Basic Materials
- Exchange
- PHVS Nasdaq
- DNN Nasdaq
- Market Cap
- PHVS 1.6B
- DNN 1.8B
- IPO Year
- PHVS 2021
- DNN 1997
- Fundamental
- Price
- PHVS $22.46
- DNN $2.92
- Analyst Decision
- PHVS Buy
- DNN
- Analyst Count
- PHVS 6
- DNN 0
- Target Price
- PHVS $36.50
- DNN N/A
- AVG Volume (30 Days)
- PHVS 217.3K
- DNN 104.0M
- Earning Date
- PHVS 11-12-2025
- DNN 11-06-2025
- Dividend Yield
- PHVS N/A
- DNN N/A
- EPS Growth
- PHVS N/A
- DNN N/A
- EPS
- PHVS N/A
- DNN N/A
- Revenue
- PHVS N/A
- DNN $3,311,190.00
- Revenue This Year
- PHVS N/A
- DNN $197.76
- Revenue Next Year
- PHVS N/A
- DNN $54.87
- P/E Ratio
- PHVS N/A
- DNN N/A
- Revenue Growth
- PHVS N/A
- DNN 12.14
- 52 Week Low
- PHVS $11.51
- DNN $1.08
- 52 Week High
- PHVS $26.33
- DNN $3.42
- Technical
- Relative Strength Index (RSI)
- PHVS 47.79
- DNN 51.56
- Support Level
- PHVS $21.99
- DNN $2.70
- Resistance Level
- PHVS $23.64
- DNN $3.30
- Average True Range (ATR)
- PHVS 1.28
- DNN 0.21
- MACD
- PHVS -0.01
- DNN -0.00
- Stochastic Oscillator
- PHVS 52.17
- DNN 39.78
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.